The efficacy and safety of disitamab vedotin combined with immune checkpoint inhibitors in metastatic upper tract urothelial carcinoma: a multicenter real-world study
迪西他单抗维多汀联合免疫检查点抑制剂治疗转移性上尿路尿路上皮癌的疗效和安全性：一项多中心真实世界研究
期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-025-04154-5
Ng, Cheoklong; Jing, Taile; Yu, Shicheng; Ye, Jianjun; Zhang, Shun; Jia, Zhankui; Tang, Qi; Hu, Xiaoyi; Chen, Minfeng; Huang, Weiping; Wu, Jitao; Bi, Hai; Yan, Zejun; Shen, Haibo; Xiong, Wei; Liu, Zheng; Xiao, Jun; Zhang, Tao; Wei, Xuedong; Hu, Hailong; Yang, Qing; Yuan, Yichu; Huang, Zhiyang; Xue, Wei; Bao, Yige; Ding, Guoqing; Xia, Dan; Huang, Jiwei
